Copyright © 2014 Pin-Yao Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Aims. To investigate the impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter, and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirin. Methods. In a case-control study including 111 low-dose aspirin users with peptic ulcers and 109 controls (asymptomatic aspirin users), the polymorphism (T-1676C) of the COX-1 gene promoter was genotyped, and blood type, H pylori status, and clinical factors were assessed. Re...
BACKGROUND: Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid ...
The new risk-factors for peptic ulcers induced by the use of nonsteroidal antiinflammatory drugs, su...
Objective: Evidence is mounting suggesting that a strong genetic component underlies aspirin insensi...
Cyclooxygenases (COX) catalyze the conversion of arachidonic acid to prostaglandins (PGs). COX-inhib...
Cyclooxygenases (COX) catalyze the conversion of arachidonic acid to prostaglandins (PGs). COX-inhib...
Background: Current knowledge about clinical and genetic risk factors for aspirin-induced gastric mu...
Contains fulltext : 87827.pdf (publisher's version ) (Open Access)BACKGROUND: Cycl...
Contains fulltext : 70838.pdf (publisher's version ) (Closed access)Aspirin preven...
The new risk-factors for peptic ulcers induced by the use of nonsteroidal antiinflammatory drugs, su...
Despite the wide benefits of aspirin and its cost-effectiveness, aspirin prescriptions have been red...
Background: The most common serious adverse effects (AEs) associated with NSAID therapy are bleeding...
Background: The most common serious adverse effects (AEs) associated with NSAID therapy are bleeding...
Cyclooxygenase-2 (COX-2) is an enzyme involved in the production of prostaglandins during inflammati...
Peptic ulcer is one of the most common gastrointestinal disorders with complex etiology. Recently we...
Background:\ud The most common serious adverse effects (AEs) associated with NSAID therapy are bleed...
BACKGROUND: Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid ...
The new risk-factors for peptic ulcers induced by the use of nonsteroidal antiinflammatory drugs, su...
Objective: Evidence is mounting suggesting that a strong genetic component underlies aspirin insensi...
Cyclooxygenases (COX) catalyze the conversion of arachidonic acid to prostaglandins (PGs). COX-inhib...
Cyclooxygenases (COX) catalyze the conversion of arachidonic acid to prostaglandins (PGs). COX-inhib...
Background: Current knowledge about clinical and genetic risk factors for aspirin-induced gastric mu...
Contains fulltext : 87827.pdf (publisher's version ) (Open Access)BACKGROUND: Cycl...
Contains fulltext : 70838.pdf (publisher's version ) (Closed access)Aspirin preven...
The new risk-factors for peptic ulcers induced by the use of nonsteroidal antiinflammatory drugs, su...
Despite the wide benefits of aspirin and its cost-effectiveness, aspirin prescriptions have been red...
Background: The most common serious adverse effects (AEs) associated with NSAID therapy are bleeding...
Background: The most common serious adverse effects (AEs) associated with NSAID therapy are bleeding...
Cyclooxygenase-2 (COX-2) is an enzyme involved in the production of prostaglandins during inflammati...
Peptic ulcer is one of the most common gastrointestinal disorders with complex etiology. Recently we...
Background:\ud The most common serious adverse effects (AEs) associated with NSAID therapy are bleed...
BACKGROUND: Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid ...
The new risk-factors for peptic ulcers induced by the use of nonsteroidal antiinflammatory drugs, su...
Objective: Evidence is mounting suggesting that a strong genetic component underlies aspirin insensi...